Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05144503

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05144503
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Lithuania (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05144503. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-22 (actual); primary completion 2029-09-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation
Acronym
SpherePVI
Intervention (Device)
SpherePVI™ Catheter
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct05144503
Content hash
790f258eb7f901abab08805337b538a91fd19a746478237568d82dd1f352931c